Patents Assigned to StemCo Biomedical, Inc.
  • Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
    Patent number: 8765119
    Abstract: A method of treating a patient with a neurodegenerative disease, such as ALS, using progenitor cells isolated from human umbilical cord blood. Non-invasive transplantation of aldehyde dehydrogenase (ALDH+) expressing progenitor cells provides cell replacement and protection of motor neurons.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: July 1, 2014
    Assignees: University of South Florida, Saneron CCEL Therapeutics, Inc., StemCo Biomedical, Inc.
    Inventors: Svitlana Garbuzova-Davis, Andrew Balber, Cyndy Davis-Sanberg, Tracy Gentry, Nicole Kuzmin-Nichols, Paul R Sanberg, Alison Willing